The role of palbociclib in thyroid carcinoma with BRAF mutation

Nikolaos Tsoukalas, Konstantinos Tsapakidis, Krystallenia I. Alexandraki


Recurrent iodine-refractory differentiated thyroid cancer (RIR-DTC) is the centre of recent investigation on endocrine oncology. The treatment of most patients with differentiated thyroid cancer (DTC) includes surgery, thyroid hormone therapy, and selective use of radioactive iodine.